Back to Journals » OncoTargets and Therapy » Volume 9

Review

Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence

       
Total article views   HTML views PDF downloads Totals
15,624 Dovepress* 13,032+ 1,803 14,835
PubMed Central* 2,592 1,101 3,693
Totals 15,624 2,904 18,528
*Since 6 September 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed and Google Scholar